Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • zybio
    Junior Member
    • Mar 2015
    • 1

    Cuffdiff splicing.diff output

    Dear all,

    I run cufflinks/cuffmege/cuffdiff pipeline on my data. But I have some problem on how to interpret the splicing.diff results.
    Here are some of my results:

    test_id gene_id gene locus sample_1 sample_2 status value_1 value_2 sqrt(JS) test_stat p_value q_value significant
    TSS2038 XLOC_001278 Q91YR5 chr1:164462249-164478706 g1 g2 OK 0 0 0.358701 2.93163e-09 4.59102e-10 1.52192e-06 yes
    TSS745 XLOC_000478 NP_001074727 chr1:138362954-138428088 g1 g2 OK 0 0 0.372363 6.93969e-07 1.27085e-07 0.000210643 yes
    TSS30120 XLOC_020929 Q80TA1,uc008wvi.1 chr5:30559157-30849030 g1 g2 OK 0 0 0.278089 3.08277e-06 5.95185e-07 0.00049326 yes

    I am wondering how can I find out the splice sites from the splicing.diff results. I'd like to check the significant splicing events visually on a genome browser. But The locus provided in splicing.diff seems to be the locus of the gene/transcript, from which I can't locate the position where the splicing event happens.

    Also, I am also confused about how to figure out the AS isoforms that are compared by cuffdiff. For example, if a genes has 5 splicing variant and cuffdiff perform a spilcing test on this gene. How could I identify the two isoforms that are compared by cuffdiff ?

    Thanks a lot!

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Working...